key: cord-0921195-460sr6iw
authors: Goshayeshi, L.; Akbari Rad, M.; Bergquist, R.; Allahyari, A.; MUMS Covid-19 Research Team,; Hoseini, B.
title: Demographic and Clinical Characteristics of the Severe Covid-19 Infections: First Report from Mashhad University of Medical Sciences, Iran
date: 2020-05-23
journal: nan
DOI: 10.1101/2020.05.20.20108068
sha: e3b967956deaff88ebaa974147d37e817fa115a4
doc_id: 921195
cord_uid: 460sr6iw

Purpose. To report a comparison between fatalities and recovery of the severe Covid-19 infected patients based on demographic and clinical characteristics. Methods. Between 5 March and 12 May 2020, of 4,000 patients, 1,278 were laboratory confirmed to be Covid-19 infection in Mashhad, Iran. Finally, 334 deceased and 733 recovered cases were assessed in terms of demography, exposure history, health outcomes and clinical symptoms. Results. Mean (SD) age for confirmed patients, for deceased cases and for recovered cases. Mean (SD) age for all confirmed-patients was 56.9 (18.74), for the fatalities 67.26 (15.77) and for those recovered 52.82 (17.91) years. The rise of the mortality rate in relation to seniority was statistically significant. Despite a high frequency of Covid-19 infections accrued in the age groups of 30-39 and 40-49 years, most of these cases (88.2 and 85.8%, respectively) recovered. The median (IQR) duration of hospitalization was 9.0 (9) days. The most prevalent co-morbidities were cardiovascular disorders (21%) and diabetes (16.3%). Fever (63.8%), cough (68.1%), and dyspnoea (72.7%) were the most frequent clinical symptoms. 5.2% of infected-cases were healthcare workers that two (3%) of them died. Most patients (48%) received both antiviral and antibiotic therapy. The mortality rate of Kaletra combination prescribed for severe cases was 46.7%. Conclusions. The characteristics of Covid-19 varied from died to survived infected patients. There were a higher number of fatalities in younger patients than in international studies. Diabetes and cardiovascular disorders were most prevalent co-morbidities. The study could not address the case-fatality rate of Covid-19 infection that remains for future studies.

In late 2019, the city of Wuhan, Hubei Province, China became the centre of an unusual pneumonia-like disease of an unknown cause [1] [2] [3] [4] . In December 2019, Chinese scientists realized that this condition was caused by a novel type of Coronavirus, first called 2019-nCOV [5, 6] . On January 7, 2020, scientists isolated this novel type of Coronavirus from the sputum of these patients, which was on February 11, 2020 classified as Severe Acute Respiratory Syndrome Coronavirus type two (SARS-CoV-2) by the International Committee on Taxonomy of Viruses [6, 7] . On the same date, the World Health Organization (WHO) named the disease caused by this virus coronavirus disease 2019 in the International Classification of Diseases [6] . As of March 11, 2020 when the Covid-19 outbreak had spread worldwide and reached 118,319 confirmed cases and 4,292 confirmed deaths, WHO declared it a global pandemic [8] [9] [10] . The initial source of Covid-19 is still unknown, but it is now confirmed that the first known case of this disease was linked to the Huanan seafood market of Wuhan City, which was closed on January 1, 2020 to control the situation [4, 11] .

SARS-CoV-2 is a member of the Coronaviridae family that consists of a single-stranded positive-sense RNA [4] . So far, two human infections by viruses related to Coronaviridae family are known: the Severe Acute Respiratory Syndrome (SARS), caused by SARS-CoV, which emerged in China in 2002 and spread across 37 countries, and the Middle-East Respiratory Syndrome (MERS), caused by MERS-CoV, which was first seen in Saudi Arabia in 2012 [4] . There were two separate outbreaks of SARS in the period 2002-2004, while cases of MERS still occur though only rarely [12] . SARS-COV-2 is genetically related to SARS-CoV with both of them being beta-coronaviruses [13, 14] .

The clinical manifestation of Covid-19 varies from asymptomatic infection to severe viral pneumonia with multiorgan failures leading to death [3, 15] . The most common clinical manifestations include, but are not limited to, fever, non-productive cough, myalgia, fatigue and dyspnoea. Chest radiography shows bilateral lung infiltrations indicative of pneumonia and blood tests produce increased sedimentation rate C-Reactive Protein and lymphocytopenia [15, 16] . In severe cases, acute respiratory distress syndrome, acute damage to the heart and kidneys as well as shock can occur and with the patient suffering a series of irreversible organ injuries leading to death [16] .

By May 16, 2020, there were 4,602,900 confirmed cases with 307,135 confirmed deaths globally, translating into a case fatality rate (CFR) of 6.67%. At this date, there were 116,635 confirmed cases with 6,902 deaths in Iran resulting in the same CFR (WHO daily report). Due to the rapid global spread of Covid-19, we estimate that an updated analysis of cases throughout one province of Iran, which consists of around 6.5 million population, might help to define more specifically define the clinical characteristics of Covid-19. Accordingly, we report here demographic and clinical characteristics of the severe Covid-19 patients comparing those deceased with those surviving in Mashhad, Iran.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 23, 2020. . https://doi.org/10.1101/2020.05.20.20108068 doi: medRxiv preprint A cross-sectional study of a local population-based cohort of patients consecutively fallen ill was conducted between 5 March and 12 May 2020 in Mashhad, Iran. Data came from the centre for Diseases Prevention and Control of Mashhad University of Medical Sciences. 94% of the cases were inpatients from hospitals affiliated to this University. Among 4,000 cases with severe symptoms, 1,278 cases were confirmed as true Covid-19 cases by realtime reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay of nasal and\or pharyngeal swabs. Clinical and demographic results from these 1,278 laboratory-confirmed cases were included in a review of exposure history, health outcomes and symptoms. Admission to an intensive care unit (ICU) or the use of mechanical ventilation within this cohort were the primary end-points. Secondary end-point was the duration of hospitalization that was defined as the time from onset of symptom(s) until discharge from the hospital as dead or recovered. The study could not calculate CFR of Covid-19 infection due to small sample size and selection bias. Fever was defined by axillary temperature of 37.5°C or higher. Prescribed medications were the Kaletra combination (ritonavir-boosted lopinavir used for treatment of HIV-1) and antibiotic which was prescribed for severe cases, and tamiflu (Oseltamivir phosphate -normally used for treatment of influenza) combination which was prescribed for mild cases.

Categorical variables were summarized as frequencies and percentages. Shapiro-Wilk tests were used to examine normality of data. Normally distributed data were expressed as mean ± standard deviation (SD), and skewed data as (Table 1) ; it should be added that only 26/1,278 (2.03%) were younger than 20 years old and only 28/1,278 (2.2%) older than 89 (Fig. 1 ). Fatality among different age groups was depicted in Figure 2 . Most the infected patients were males (793/1,278 = 62%). There was no statistically significant difference in outcomes with reference to gender (Table 1) .

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 23, 2020. Hospitalization (days) -median (IQR) N= 1,027 9 (10) 9 (9) 0.1 a prescribed for severe cases; b prescribed for mild cases.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 23, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 23, 2020. The median (IQR) duration of hospitalization was 9.0 (9) days and there was not statistically significant difference between duration of those who discharged and those who died (Table 1) . is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 23, 2020. . https://doi.org/10.1101/2020.05.20.20108068 doi: medRxiv preprint 

This is the first research in Mashhad, Iran to report the characteristics of the severe Covid-19 patients with their infections confirmed by RT-PCR. The study found that a rising age in this group of patients enhance the risk of mortality. The most frequent co-morbidities were diabetes and cardiovascular disorders and the most frequent symptoms dyspnoea, cough, and fever. In addition, the most frequent infections occurred in age groups of 50-59 and 60-69 years, while the highest rate of fatality was in the age group of 80-89 years. These findings are in line with other researchers' reported findings [6, 17] .

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 23, 2020. . https://doi.org/10.1101/2020.05.20.20108068 doi: medRxiv preprint According to our data, the mean (SD) age of Iranian Covid-19 patients is 56.9 (18.74) years, which is in agreement with other studies [16, 18, 19] , but older than that reported by Guan et al. [20] who reported a median age (IQR) of 47.0 (35.0 -58.0) years where 55.1% of their cases were between 15-49 years old (1) and also younger than the 64 years reported in other studies [21, 22] . Although, the most frequent Covid-19 infection occurred in the 50-59 and 60-69 age groups, the frequency of infection was also considerable in age groups of 30-39 and 40-49 years. The high frequency of Covid-19 infection in these age groups may be due to low median age (30 years) of the Iranian population and/or due to inclusion of mainly working-age population in this age group [23] . It seems that the frequency of Covid-19 infections rises considerably from age group of 50-59 years [24] . In contrast to findings in China and Italy [6, 25] , we found a considerably higher proportion of fatalities in the age groups panning the range from 20 to 50 year of age.

Although our findings revealed statistically no significant association between gender and the outcome of Covid-19 infection, the prevalence of the Covid-19 infection was higher among Iranian men when compared with the reports of China. 62% of our cases were males while it only (49.3% -54.3%) in China [16, 21] . However, our finding was in line with the reports of Italy (60%) [26] , and the United States (63%) [22] .

Huang et al.'s study [17] reported 15% CFR in China. However, they study only admitted hospital cases, leading to selection bias, as according to WHO daily report 5.6% CFR is reported in China by May 10, 2020. At the beginning of the Covid-19 outbreak in Italy, CFR was reported 11.8% (12,430/105,792) [27] for this country, but it is decreased as their sample size is increased. In our study, owing to resource restriction, RT-PCR testing was only used for cases with severe symptom at a high risk of mortality compared to other patients, leading to selection bias.

Another limitation could be the inclusion of a comparatively low number of cases detected within a short timehorizon. Regarding these limitations and to avoid reporting misleading result, our study did not address calculating CFR that remains for future studies. A long-term screening of all population at risk in future should let us to report a more reliable CFR. The more important infection fatality rate (IFR) would also be of interest but would require a reliable antibody detection assay and a rather large human's sample, which would be beyond the aims of this study.

According to WHO interim clinical guidance (Rev. March 20, 2020) [28], fever, caught, fatigue and anorexia are the most common signs of Covid-19 and our findings comply. However, in the case of dyspnoea, our results (72.7%) were twice the prevalence suggested by WHO (31-40%) [28] . On the other hand, they were in line with other studies reported from United States [22, 29] . It is noteworthy that the prevalence of dyspnoea in the Chinese population complies with the WHO guidelines [18, 21, 30] , while they can also be slightly higher [31] . It seems that the WHO should update the information based on new global data pointing out that there may be differences with respect to region.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 23, 2020. .

Cardiovascular disorders (21%) and diabetes (16.3%) were the most prevalent co-morbidities among Covid-19 patients in our study. Previous studies have reported diverse prevalence rates ranging from 11% to 45% for cardiovascular disorders and from 13% to 35% for diabetes [18, 22, 29, 32] . A meta-analysis reports an overall pooled prevalence of 8.4% and 9.7% [33] for cardiovascular disorders and diabetes, respectively, while another meta-analysis reports 12% and close to 8% [34] . As soon as the pandemic started in Iran, the National Covid-19

Committee was set up and raised awareness of the risk, bringing forth the hypothesis that awareness of the infection risk may be associated with lower prevalence of co-morbidities. Assessing the association between patients' awareness and adherence to the prevention protocols remains for the future studies.

The fatality rate among healthcare workers was 3% in our study is considerably higher than that (0.33%) reported in China [35] . It might be due to shortage of protection equipment in the beginning of the Covid-19 pandemic in Iran.

Future studies will confirm after fixing the shortage of protection equipment whether fatality has decreased among healthcare workers or not. The low number of health workers in our material (5.2%) could also have played a role.

While it was reported by Huang et al. that 32% of patients were admitted to ICU [36] , we only transferred 11.8% of cases there. In addition, the fatality rate in the ICU in our study was 46.4%, which is lower than that (78%) reported by Zhou et al. [6] . All patients admitted to ICU received broad-spectrum antibiotics and antiviral medications, a combination that may have contributed to the lower mortality rate. Examination of this hypothesis remains for future studies. Another reason is that ICU care was carried out by an expert hospital team. Importantly, the use if the RT-PCR testing of all ICU-admitted patients strengthened the reliability of the fatality rate of this category of patients.

To our knowledge, this is the first study addressed the characteristics of Covid-19 patients confirmed by RT-PCR in Mashhad, Iran. However, RT-PCR testing was mostly only applied to cases with severe symptoms. This selection bias accompanied with too small sample size did not let us to calculate and report CFR in our study that remains for future studies. Because many patients were under treatment and the outcomes were unknown at cut-off date, we could not analyse their clinical outcomes at the analyses time. Owing to incomplete laboratory testing at the time, we could not analyse laboratory data which therefore remain for future studies. The data analysed here came from Mashhad University of Medical Sciences which do not cover all areas of Razavi Khorasan and this might have led to exclusion of cases from some region of the study area. Despite above-mentioned limitation, we feel that the findings are informative and also brings forth new hypotheses that can be examined in the future.

The frequency of Covid-19 fatalities rose considerably from age group of 30-39 years, but there were a higher number of fatalities in younger patients than in international studies. Diabetes and cardiovascular disorders were most prevalent co-morbidities, although lower than reported in previous studies. Fever, cough, and dyspnoea were common symptoms among the patients infected with Covid-19, however fever and cough were not common among those who eventually died cases compared those who recovered.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 23, 2020. . https://doi.org/10.1101/2020.05.20.20108068 doi: medRxiv preprint

A Novel Coronavirus Emerging in China -Key Questions for Impact Assessment. The New England journal of medicine

Full spectrum of COVID-19 severity still being depicted -Authors' reply. The Lancet

Clinical Characteristics of Coronavirus Disease 2019 in China

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Origin and evolution of the 2019 novel coronavirus

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

First known person-toperson transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA

COVID-19) situation report -51. World Health Organisation

Epidemiology, Pathogenesis, and Control of COVID-19

Water soluble, optically active monofunctional Pd(ii) and Pt(ii) compounds: promising adhesive and antimigratory effects on human prostate PC-3 cancer cells

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

Origin and evolution of the 2019 novel coronavirus -Supplementary data

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Association of soil arsenic and nickel exposure with cancer mortality rates, a town-scale ecological study in Suzhou, China. Environmental science and pollution research international

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Clinical characteristics of coronavirus disease 2019 in China

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

Covid-19 in Critically Ill 26

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region

Journal of medical virology. 2020. 28. WHO. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19) 2020

Critically Ill Patients With COVID-19 in Washington State

Imaging and clinical features of patients with

novel coronavirus SARS-CoV-2. European journal of nuclear medicine and molecular imaging

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine

Isolation and characterization of 2019-nCoV-like coronavirus from Malayan pangolins

Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis

Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis. Archives of academic emergency medicine

Tribute to health workers in China: A group of respectable population during the outbreak of the COVID-19

Clinical features of patients infected with 2019 novel coronavirus in Wuhan